Valuation : ArcticZymes Technologies ASA

Market Cap 1.07B 115M 99.25M 93.38M 85.3M 160M 10.89B 160M 1.1B 428M 5.59B 433M 424M 18B P/E 2026 *
68.5x
P/E 2027 * 39.3x
Enterprise Value 794M 85.39M 73.47M 69.13M 63.15M 118M 8.06B 118M 817M 317M 4.14B 321M 314M 13.32B EV / Sales 2026 *
5.67x
EV / Sales 2027 * 4.78x
Free-Float
82.59%
Yield 2026 *
-
Yield 2027 * -
1 day-1.41%
1 week+0.96%
Current month+0.48%
1 month+7.69%
3 months+1.94%
6 months-9.87%
Current year+1.94%
1 week 20.5
Extreme 20.5
21.7
1 month 18.7
Extreme 18.7
22
Current year 18.3
Extreme 18.3
26.6
1 year 18.3
Extreme 18.3
31.4
3 years 12.34
Extreme 12.34
43.2
5 years 12.34
Extreme 12.34
100
10 years 3.5
Extreme 3.5
114.4
Manager TitleAgeSince
Chief Executive Officer - 2023-09-17
Director of Finance/CFO 51 2014-09-30
Chief Tech/Sci/R&D Officer 43 -
Director TitleAgeSince
Chairman 64 2024-06-25
Director/Board Member 62 2024-06-25
Director/Board Member - -
Date Insider Type Main position Quantity % Market Cap. Importance
8/14/25 Buy

Director

2,852 0.0056%
6/4/25 Buy

Chief Operating Officer

3,400 0.0067%
5/14/25 Exercice

Chief Operating Officer

15,000 0.0294%
Change 5-day change 1-year change 3-year change Capi.($)
-1.41%+0.96%-24.19%-34.38% 117M
-0.88%-2.15%+54.71%+105.91% 1,034B
-1.15%+2.68%+53.97%+71.29% 671B
-1.44%+0.38%+20.40%+75.54% 460B
+0.14%-1.92%+32.47%+37.60% 353B
-1.33%+3.96%+25.71%+45.03% 309B
-1.15%-0.89%-1.67%+12.21% 255B
-1.55%+1.11%+56.10%+72.13% 240B
-0.88%+1.24%-18.03%-54.06% 207B
-0.15%+3.65%+33.90%+100.90% 188B
Average -1.48%+1.38%+23.34%+43.22% 371.69B
Weighted average by Cap. -1.30%+1.04%+36.92%+66.55%

Financials

2026 *2027 *
Net sales 140M 15.06M 12.96M 12.19M 11.14M 20.83M 1.42B 20.89M 144M 55.9M 729M 56.54M 55.31M 2.35B 160M 17.23M 14.82M 13.95M 12.74M 23.83M 1.63B 23.9M 165M 63.95M 834M 64.68M 63.27M 2.69B
Net income 15.66M 1.68M 1.45M 1.36M 1.25M 2.33M 159M 2.34M 16.11M 6.25M 81.58M 6.32M 6.19M 263M 27.28M 2.93M 2.52M 2.38M 2.17M 4.06M 277M 4.07M 28.07M 10.89M 142M 11.02M 10.78M 458M
Net Debt -279M -29.95M -25.78M -24.25M -22.15M -41.44M -2.83B -41.56M -287M -111M -1.45B -112M -110M -4.67B -306M -32.94M -28.35M -26.67M -24.36M -45.58M -3.11B -45.7M -315M -122M -1.6B -124M -121M -5.14B
Logo ArcticZymes Technologies ASA
Arcticzymes Technologies ASA is a Norway-based holding company providing support functions to the ArcticZymes AS subsidiary including distribution, administration, finance, Information Technology (IT) and quality assurance. As a life science company, Arcticzymes Technologies ASA is focused on the development, manufacturing, and commercialization of novel and high-quality recombinant enzymes for use in molecular research, In Vitro Diagnostics (IVD) and biomanufacturing. Some of the key features of the Company’s enzymes include cold activeness and salt tolerance. The Company’s divided into two operating segments; Enzymes and Corporate. Arcticzymes established logistic hubs in the United States and the Netherlands to serve its customers more efficiently.
Employees
51
Date Price Change Volume
26-09-04 NOK 21.00 -1.41% 12,735
26-09-03 NOK 21.30 +1.43% 38,669
26-09-02 NOK 21.00 +1.45% 17,620
26-09-01 NOK 20.70 -0.96% 9,097
26-08-31 NOK 20.90 +1.95% 56,868
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
21.30NOK
Average target price
28.00NOK
Spread / Average Target
+31.46%

Quarterly revenue - Rate of surprise